Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-42.24% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFM · Mar 31, 2024
Sunshine Biopharma Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001683168-24-003688General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
54.09% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
102.08% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
31.22% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-17.91% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.94% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History30 statesSelf-history eligible
Dec 31, 20214/7 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/7 normalizedLevel 3Dec 31, 20236/7 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedAmended as filedSep 30, 20246/6 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -36.42%
- Current
- -42.24%
- Delta
- -5.82%
- Previous
- 454.42%
- Current
- 54.09%
- Delta
- -400.33%
- Previous
- 23.80%
- Current
- 102.08%
- Delta
- 78.28%
- Previous
- 34.61%
- Current
- 31.22%
- Delta
- -3.39%
- Previous
- -19.86%
- Current
- -17.91%
- Delta
- 1.95%
- Previous
- 7.70%
- Current
- 2.94%
- Delta
- -4.76%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · SBFM Fundamental State →Analogous To · SBFM state analogue 2 →Transitioned To · SBFM Fundamental State →Transitioned To · SBFM CASH_GENERATION_DECREASED →Transitioned To · SBFM GROWTH_DECREASED →Transitioned To · SBFM INVENTORY_PRESSURE_INCREASED →Transitioned To · SBFM MARGIN_DECREASED →Transitioned To · SBFM PROFITABILITY_INCREASED →Transitioned To · SBFM R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.